Healthtech Series C Investors & VC Firms

771 firms in this list, with a median first check of $1M. 164 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
PE Pender Ventures MPCCMLJH12 people · Leads rounds	88🔒	Vancouver	CA	Seed–Late Stage	—	+ Add to CRM
TW Twin Path Ventures JSKLNSLQ4 people · Leads rounds	88🔒	London	GB	Pre-Seed–Growth	$952.5K	+ Add to CRM
SO Sound Bioventures CBJKAGES9 people · Leads rounds	88🔒	Malmö	SE	Seed–Late Stage	—	+ Add to CRM
EL Elad Gil EG1 person · Leads rounds	88🔒	San Francisco	US	Seed–Growth	$100K – $10M	+ Add to CRM
AM Amplitude Venture Capital MMAGBSDM16 people · Follows rounds	88🔒	Montreal	CA	Seed–Late Stage	—	+ Add to CRM
AR Aroa Venture Partners GGNWSPSG13 people · Follows rounds	88🔒	Gurgaon	IN	Pre-Seed–Series C	$100K – $500K	+ Add to CRM
B- B-FLEXION APNLSAFW13 people	88🔒	St. Helier	US	Seed–Late Stage	$500K	+ Add to CRM
BR Bridge Bank BCBLDMDB16 people	88🔒	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
IN Infinitas Capital RLSLACAL16 people	88🔒	—		Pre-Seed–Late Stage	—	+ Add to CRM
TE Tencent Holdings CYXCZLZZ19 people	88🔒	Shenzhen	CN	Seed–Growth	$3.9M – $400M	+ Add to CRM
VE Vertex Venture Management Pte. Ltd. CKCSJCCS16 people	88🔒	Singapore	SG	Pre-Seed–Growth	—	+ Add to CRM
IN International Finance Corporation MDAGEBET12 people · Follows rounds	88🔒	Washington D.C.	US	Seed–Late Stage	$20M – $500M	+ Add to CRM
KI Kiraboshi Capital	88🔒	Tokyo	JP	Pre-Seed–Late Stage	—	+ Add to CRM
DE Detong Capital JTRSSJTL11 people	88🔒	Shanghai	CN	Seed–Late Stage	$20M	+ Add to CRM
GR GR Capital MFDLSKAL6 people · Follows rounds	88🔒	London	GB	Series A–Growth	$3.2M – $10.8M	+ Add to CRM
NU Nueterra Capital DTJTBTEE6 people	88🔒	Leawood	US	Seed–Late Stage	—	+ Add to CRM
TE Texas Ventures ESACAVHM6 people	88🔒	Houston	US	Seed–Late Stage	—	+ Add to CRM
IS ISA Ventures EE1 person	88🔒	Cedar Rapids	US	Pre-Seed–Late Stage	$25K – $1M	+ Add to CRM
EL Elysian Park Ventures CVJANBPV10 people	88🔒	Los Angeles	US	Seed–Growth	$500K – $100M	+ Add to CRM
JS JStar Capital Investments EPJLBBDD13 people	88🔒	Austin	US	Seed–Late Stage	—	+ Add to CRM
AG AgeTech Capital AMBSLLST15 people	88🔒	Toronto	CA	Pre-Seed–Growth	—	+ Add to CRM
GL Global BioAccess Fund BRLWLWTM11 people	88🔒	New York	US	Series A–Late Stage	$10M	+ Add to CRM
FO Founders Future GSLSMMSD15 people	88🔒	Paris	FR	Pre-Seed–Growth	—	+ Add to CRM
VI Viola Credit AGEFIVAB12 people · Follows rounds	88🔒	London	GB	Pre-Seed–Late Stage	$2M – $50M	+ Add to CRM

Pender Ventures

VancouverSeed–Late Stage

MPCCMLJH12 people

Twin Path Ventures

LondonPre-Seed–Growth$952.5K

JSKLNSLQ4 people

Sound Bioventures

MalmöSeed–Late Stage

CBJKAGES9 people

Elad Gil

San FranciscoSeed–Growth$100K – $10M

EG1 person

Amplitude Venture Capital

MontrealSeed–Late Stage

MMAGBSDM16 people

Aroa Venture Partners

GurgaonPre-Seed–Series C$100K – $500K

GGNWSPSG13 people

B-FLEXION

St. HelierSeed–Late Stage$500K

APNLSAFW13 people

Bridge Bank

San FranciscoSeed–Late Stage

BCBLDMDB16 people

Infinitas Capital

Pre-Seed–Late Stage

RLSLACAL16 people

Tencent Holdings

ShenzhenSeed–Growth$3.9M – $400M

CYXCZLZZ19 people

Vertex Venture Management Pte. Ltd.

SingaporePre-Seed–Growth

CKCSJCCS16 people

International Finance Corporation

Washington D.C.Seed–Late Stage$20M – $500M

MDAGEBET12 people

Kiraboshi Capital

TokyoPre-Seed–Late Stage

Detong Capital

ShanghaiSeed–Late Stage$20M

JTRSSJTL11 people

GR Capital

LondonSeries A–Growth$3.2M – $10.8M

MFDLSKAL6 people

Nueterra Capital

LeawoodSeed–Late Stage

DTJTBTEE6 people

Texas Ventures

HoustonSeed–Late Stage

ESACAVHM6 people

ISA Ventures

Cedar RapidsPre-Seed–Late Stage$25K – $1M

EE1 person

Elysian Park Ventures

Los AngelesSeed–Growth$500K – $100M

CVJANBPV10 people

JStar Capital Investments

AustinSeed–Late Stage

EPJLBBDD13 people

AgeTech Capital

TorontoPre-Seed–Growth

AMBSLLST15 people

Global BioAccess Fund

New YorkSeries A–Late Stage$10M

BRLWLWTM11 people

Founders Future

ParisPre-Seed–Growth

GSLSMMSD15 people

Viola Credit

LondonPre-Seed–Late Stage$2M – $50M

AGEFIVAB12 people

Data sourced from public filings and firms' own websites — see our methodology.